Revolution Medicines, Inc. — Director's Dealing 2021

Mar 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Revolution Medicines, Inc. (RVMD)
CIK: 0001628171
Period of Report: 2021-03-22

Reporting Person: Miller Vincent A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-22	Common Stock	M	3200	$4.73	Acquired	23333	Direct
2021-03-22	Common Stock	S	3200	$49	Disposed	20133	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-22	Stock Option (Right to Buy)	$4.73	M	1600	Disposed	2029-08-08	Common Stock (1600)	Direct
2021-03-22	Stock Option (Right to Buy)	$4.73	M	1600	Disposed	2029-08-08	Common Stock (1600)	Direct

Footnotes

F1: Includes 1,808 Restricted Stock Units.

F2: The option is early exercisable. One twenty-fourth (1/24th) of the shares initially subject to the option will vest on each monthly anniversary measured from August 9, 2019 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the second anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

F3: The option is early exercisable. One twelfth (1/12th) of the shares initially subject to the option will vest on each monthly anniversary measured from September 27, 2019 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.